Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
about
Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) QuestionnairePhysical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitisTranslation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaireNon-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Self management programme for ankylosing spondylitisNon-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondyloarthritis) and gastrointestinal or liver comorbidityCombination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritisMeasures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds EnEnteropathic arthritis in Brazil: data from the Brazilian Registry of Spondyloarthritis.The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomesAdaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) instrument for Sweden.Patient reported outcomes: looking beyond the label claim.A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD).Development of the US PSORIQoL: a psoriasis-specific measure of quality of life.Spondyloarthritides: evolving therapiesPsychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis.Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trialHealth status of patients with ankylosing spondylitis: a comparison with the general population.Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study.Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinicDiscriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic aMaintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumabThe British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment.Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS.How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?Seronegative spondyloarthropathies: to lump or split?Web-based physiotherapy for people with axial spondyloarthritis (WEBPASS) - a study protocol.Adaptation of Chinese and English versions of the Psoriatic Arthritis Quality of Life (PsAQoL) scale for use in SingaporeClinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.Greek adaptation and validation of the Ankylosing Spondylitis Quality of Life (ASQoL) measureAdaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) into French-Canadian and English-CanadianAdalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort.Improving the psychological evaluation of exercise referral: Psychometric properties of the Exercise Referral Quality of Life Scale.Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.Real-life experience of using conventional disease-modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA in comparison to spondyloarthritidAre clinical measures influenced by various ethnic origins in Iranian patients with ankylosing spondylitis?A pilot study.Affective temperament profile in ankylosing spondylitis patients using TEMPS-A
P2860
Q21133692-0347BBDD-F404-4D56-8899-237142AF7F82Q21195369-8CBC49D2-9F9D-406C-8A75-8644811C0873Q21245615-F762B1F3-F1B4-4CEE-9373-1667CE356CFCQ24186403-E1D379CA-4190-40B7-8397-8E27961AF53CQ24187492-0367C527-36D5-404D-9CA6-A5856BF11B37Q24201300-E569C5E4-C11C-4954-B144-FC04E557FFE4Q24203871-7224807C-A5CD-4144-A34F-62B2B82FA10EQ24235846-19A3F342-D287-4C7D-BDCD-6716CC6FCB22Q24673687-F6527359-4765-49F1-B08A-30A16D584F5EQ26862017-ACB9AAA6-0C0B-47F1-9F88-2B2648B69820Q30745189-695A6A7B-A2D6-42CC-9205-9E78F67B8F0BQ33916770-D139BF59-3787-4EE0-9885-4CEE9B9798E9Q34092035-5D06902B-975F-4129-913D-14C8985D873EQ34114747-735B13DB-D8F9-449D-AA19-4D99FB549B71Q34302550-692EDF3B-3B75-47D3-B666-98D12ADA1B36Q34424519-D18B16AB-2606-4B17-AE70-A2B0E6E8FB9DQ34613907-15F10521-590B-44C8-9F3D-AD0BD4F61FC4Q35071645-A5E8D13E-0D5F-4B04-8FB3-9989DFF511CBQ35537104-34177FF9-F9F5-43DC-B955-68A8C8B50604Q35553676-13B97E4B-60C5-41F9-9F71-174E1A6F9D62Q35554918-9BE21C90-DE70-4406-8E62-922F5E6DDA04Q35638281-1479F757-0D0B-49AA-8298-C9515839D9B8Q35664666-E69F2AB5-9725-4F26-888C-AB26B223C2BDQ35759171-1B4E0FF1-DF32-460E-B3A8-0C0D550E8146Q35838797-5B352992-1111-4958-93F6-339D86CB735AQ35880376-02CB07C8-1FED-4A33-9555-2FB59CCEEE7CQ35953430-4B792FF2-1B11-46C0-A7DC-B086593FE8C3Q36040093-39A959E7-57CE-4CAF-99D6-1917ACAA7484Q36110768-3042D73B-977E-4A33-9586-31753AA5AEEEQ36166729-754E0461-76F8-49DC-A5D3-5807A04BDB43Q36907291-EC73FE42-C5EA-48BE-AC76-AD853E989585Q37078444-5A78D58A-31EF-43A8-868A-33ACA39342CBQ37114630-C89FB69A-FB96-4C7E-A36A-1A28C6C540E9Q37172795-963F7155-96A6-4A3A-9B10-59B2B25C1D56Q37530561-10939ECC-587B-4533-824B-90CF0D04A5C2Q37540721-5BB6B175-0845-4010-95B6-DF5120F03B8EQ37612248-B8B6A2A1-CB65-4A98-AFB3-257A940240ADQ37679286-F9DD2D1E-F6C5-4656-A3FF-6324F5123261Q37711121-F280DCC4-6BF8-4BDD-BC6F-9E66FD3CDBF3Q37714745-4CD143D2-B258-4A28-B9A2-D3B3ADB8E320
P2860
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
@ast
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
@en
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
@nl
type
label
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
@ast
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
@en
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
@nl
prefLabel
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
@ast
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
@en
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
@nl
P2093
P2860
P3181
P356
P1476
Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
@en
P2093
Chamberlain MA
Helliwell PS
McKenna SP
Spoorenberg A
van der Heijde D
P2860
P3181
P356
10.1136/ARD.62.1.20
P407
P5530
P577
2003-01-01T00:00:00Z
P5875
P6179
1006904651